Literature DB >> 17520411

Diagnosis and treatment of menorrhagia.

R Hurskainen1, S Grenman, I Komi, E Kujansuu, R Luoto, M Orrainen, K Patja, J Penttinen, S Silventoinen, J Tapanainen, J Toivonen.   

Abstract

One-third of all women experience heavy menstrual bleeding at some point in their life. In western countries, about 5% of women of reproductive age will seek help for menorrhagia annually. Half of all women who consult for hypermenorrhea have some uterine abnormality, most often fibroids (among patients under 40 years of age) and endometrial polyps (above 40 years of age). Appropriate treatment considerably improves the quality of life of these patients, and it is important to make a rigorous assessment of the patient to provide the best treatment options. This guideline provides instructions on how to examine and treat women of fertile age who have menorrhagia. The subject's own assessment of the amount of menstrual blood loss does not generally reflect the true amount. All patients should undergo a pelvic examination and, if the menstrual pattern has changed substantially or if anaemia is present, a vaginal sonography should be carried out as the most important supplemental examination. Vaginal sonography combined with an endometrial biopsy is a reliable method for diagnosing endometrial hyperplasia or carcinoma, but it is insufficient for diagnosing endometrial polyps and fibroids; these can be diagnosed more reliably by sonohysterography or hysteroscopy. Non-steroidal anti-inflammatory drugs and tranexamic acid reduce menstrual blood loss by 20-60%, and the effectiveness of a hormonal intrauterine system (IUS) is comparable with that of endometrial ablation or hysterectomy. Cyclic progestogens do not significantly reduce menstrual bleeding of women who ovulate. Treatment should be started with one of the drug therapies, i.e. the IUS, tranexamic acid, anti-inflammatory drugs, or oral contraceptive. Drug treatment should be used and evaluated before surgical interventions are considered. With an effective training and feedback system, it is possible to organise the diagnostics, medical treatment and follow-up of heavy menstrual bleeding in the primary health care setting or in outpatient clinics, which reduces the burden on specialist health care.

Entities:  

Mesh:

Year:  2007        PMID: 17520411     DOI: 10.1080/00016340701415400

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  8 in total

1.  PURLs: consider this option for heavy menstrual bleeding.

Authors:  Robert Levy; Shailendra Prasad; Kate Rowland
Journal:  J Fam Pract       Date:  2011-07       Impact factor: 0.493

Review 2.  Interventions for heavy menstrual bleeding; overview of Cochrane reviews and network meta-analysis.

Authors:  Magdalena Bofill Rodriguez; Sofia Dias; Vanessa Jordan; Anne Lethaby; Sarah F Lensen; Michelle R Wise; Jack Wilkinson; Julie Brown; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2022-05-31

3.  Does the working temperature affect the outcome following microwave endometrial ablation?

Authors:  M Harmon; A V Kasbekar; A Sinha; V Andrews
Journal:  Ir J Med Sci       Date:  2016-06-30       Impact factor: 1.568

4.  Effective treatment of heavy and/or prolonged menstrual bleeding without organic cause: pooled analysis of two multinational, randomised, double-blind, placebo-controlled trials of oestradiol valerate and dienogest.

Authors:  Ian S Fraser; Susanne Parke; Uwe Mellinger; Andrea Machlitt; Marco Serrani; Jeffrey Jensen
Journal:  Eur J Contracept Reprod Health Care       Date:  2011-08       Impact factor: 1.848

5.  Next-generation NovaSure device for endometrial ablation: assessing ease-of-use among physicians.

Authors:  Whitney Pollock; William Jamieson
Journal:  Int J Womens Health       Date:  2012-03-14

6.  The influence of haemoglobin and iron on in vitro mycobacterial growth inhibition assays.

Authors:  Rachel Tanner; Matthew K O'Shea; Andrew D White; Julius Müller; Rachel Harrington-Kandt; Magali Matsumiya; Mike J Dennis; Eneida A Parizotto; Stephanie Harris; Elena Stylianou; Vivek Naranbhai; Paulo Bettencourt; Hal Drakesmith; Sally Sharpe; Helen A Fletcher; Helen McShane
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

7.  Endometrial Cryoablation for the Treatment of Heavy Menstrual Bleeding: 36-Month Outcomes from the CLARITY Study.

Authors:  Howard L Curlin; Ted L Anderson
Journal:  Int J Womens Health       Date:  2022-08-10

8.  Prevalence and knowledge of heavy menstrual bleeding among gynecology outpatients by scanning a WeChat QR Code.

Authors:  Sisi Su; Xin Yang; Qing Su; Yang Zhao
Journal:  PLoS One       Date:  2020-04-02       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.